Amicus Therapeutics, Inc. (FOLD) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Campbell Bradley L mit 998,680 Aktien. Weitere bedeutende Anteilseigner sind Crowley John F und Rosenberg Ellen.
In den letzten 12 Monaten haben Insider 33 Transaktionen in FOLD Aktien getätigt — 9 Käufe (im Wert von $3.12M) und 5 Verkäufe (im Wert von $1.47M). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
FOLD Insider-Beteiligungen
Größter Aktionär
Campbell Bradley L
998,680 Aktien
Käufe (12 Monate)
9
$3.12M Wert
Verkäufe (12 Monate)
5
$1.47M Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Campbell Bradley L |
President and CEO |
998,680 |
2026-03-04 |
|
| 2 |
Crowley John F |
Executive Chairman |
958,627 |
2024-03-15 |
|
| 3 |
Rosenberg Ellen |
Chief Legal Officer |
494,284 |
2026-01-06 |
|
| 4 |
Do Hung |
Chief Science Officer |
448,617 |
2021-04-08 |
|
| 5 |
Castelli Jeff |
Chief Development Officer |
432,413 |
2026-01-06 |
|
| 6 |
Quimi Daphne |
Chief Financial Officer |
405,455 |
2023-01-19 |
|
| 7 |
Clark David Michael |
Chief People Officer |
240,309 |
2026-01-06 |
|
| 8 |
Harford Simon N.r. |
Chief Financial Officer |
143,595 |
2025-12-30 |
|
| 9 |
Prout Samantha |
Chief Accounting Officer |
138,191 |
2026-01-06 |
|
| 10 |
Bleil Lynn Dorsey |
Director |
74,872 |
2025-06-06 |
|
| 11 |
Sblendorio Glenn |
Director |
74,872 |
2025-06-06 |
|
| 12 |
Raab Michael |
Director |
74,872 |
2025-06-06 |
|
| 13 |
Mcglynn Margaret G |
Director |
74,872 |
2025-06-06 |
|
| 14 |
Whitman Burke W |
Director |
74,872 |
2025-06-06 |
|
| 15 |
Wheeler Craig A |
Director |
74,872 |
2025-06-06 |
|
| 16 |
Roberts Eiry |
Director |
74,872 |
2025-06-06 |
|
| 17 |
Kelly Michael Aaron |
Director |
72,468 |
2025-06-06 |
|
| 18 |
Essner Robert |
Director |
31,115 |
2021-06-14 |
|
| 19 |
Love Ted W |
Director |
18,574 |
2020-06-08 |
|
| 20 |
Barth Jay |
Chief Medical Officer |
14,666 |
2020-10-02 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-03-02 |
Campbell Bradley L |
President and CEO |
Informierter Verkauf |
22,500 |
$14.35 |
$322.84K |
| 2026-01-20 |
Campbell Bradley L |
President and CEO |
Optionsausübung (Verkauf) |
75,000 |
$6.10 |
$457.5K |
| 2026-01-03 |
Clark David Michael |
Chief People Officer |
RSU-Steuereinbehalt |
18,498 |
$14.27 |
$263.97K |
| 2026-01-02 |
Clark David Michael |
Chief People Officer |
RSU-Steuereinbehalt |
5,381 |
$14.27 |
$76.79K |
| 2026-01-03 |
Prout Samantha |
Chief Accounting Officer |
RSU-Steuereinbehalt |
12,240 |
$14.27 |
$174.66K |
| 2026-01-02 |
Prout Samantha |
Chief Accounting Officer |
RSU-Steuereinbehalt |
3,443 |
$14.27 |
$49.13K |
| 2026-01-03 |
Rosenberg Ellen |
Chief Legal Officer |
RSU-Steuereinbehalt |
29,683 |
$14.27 |
$423.58K |
| 2026-01-02 |
Rosenberg Ellen |
Chief Legal Officer |
RSU-Steuereinbehalt |
13,426 |
$14.27 |
$191.59K |
| 2026-01-03 |
Castelli Jeff |
Chief Development Officer |
RSU-Steuereinbehalt |
23,102 |
$14.27 |
$329.67K |
| 2026-01-02 |
Castelli Jeff |
Chief Development Officer |
RSU-Steuereinbehalt |
6,905 |
$14.27 |
$98.53K |
| 2025-12-26 |
Harford Simon N.r. |
Chief Financial Officer |
RSU-Steuereinbehalt |
71,303 |
$14.25 |
$1.02M |
| 2025-12-26 |
Campbell Bradley L |
President and CEO |
RSU-Steuereinbehalt |
108,602 |
$14.25 |
$1.55M |
| 2025-12-19 |
Clark David Michael |
Chief People Officer |
Informierter Verkauf |
25,642 |
$14.17 |
$363.38K |
| 2025-12-15 |
Clark David Michael |
Chief People Officer |
Informierter Verkauf |
25,643 |
$11.00 |
$282.07K |
| 2025-12-15 |
Campbell Bradley L |
President and CEO |
Optionsausübung (Verkauf) |
70,426 |
$9.03 |
$635.95K |
| 2025-12-01 |
Prout Samantha |
Chief Accounting Officer |
RSU-Zuteilung |
32,193 |
- |
- |
| 2025-12-01 |
Campbell Bradley L |
President and CEO |
Optionsausübung (Verkauf) |
14,587 |
$9.03 |
$131.72K |
| 2025-11-24 |
Clark David Michael |
Chief People Officer |
Informierter Verkauf |
25,643 |
$10.10 |
$258.93K |
| 2025-11-26 |
Rosenberg Ellen |
Chief Legal Officer |
Optionsausübung (Verkauf) |
23,621 |
$5.13 |
$121.18K |
| 2025-11-25 |
Rosenberg Ellen |
Chief Legal Officer |
Optionsausübung (Verkauf) |
36,000 |
$5.13 |
$184.68K |
| 2025-11-24 |
Rosenberg Ellen |
Chief Legal Officer |
Optionsausübung (Verkauf) |
25,000 |
$6.10 |
$152.5K |
| 2025-11-24 |
Castelli Jeff |
Chief Development Officer |
Optionsausübung (Verkauf) |
50,000 |
$9.03 |
$451.5K |
| 2025-11-24 |
Campbell Bradley L |
President and CEO |
Optionsausübung (Verkauf) |
14,587 |
$9.03 |
$131.72K |
| 2025-11-04 |
Clark David Michael |
Chief People Officer |
Informierter Verkauf |
25,643 |
$9.51 |
$243.86K |
| 2025-08-21 |
Harford Simon N.r. |
Chief Financial Officer |
RSU-Steuereinbehalt |
12,529 |
$7.60 |
$95.22K |
